Ligand validation:6L0P

E1U: (2S)-2-[(E)-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylideneamino]-3-phosphonooxy-propanoic acid

E1U is a Ligand Of Interest in 6L0P designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6L0P_E1U_B_401	82%	10%	0.102	0.956	1.94	2.38	6	11	0	0	100%	1
6L0P_E1U_D_401	81%	5%	0.102	0.955	2.88	2.49	10	8	1	0	100%	1
6L0P_E1U_A_401	74%	3%	0.114	0.944	2.58	3.68	10	9	0	0	100%	1
6L0P_E1U_C_401	72%	16%	0.127	0.951	2.16	1.57	8	8	0	0	100%	1
6L0Q_E1U_D_401	73%	17%	0.109	0.937	1.97	1.65	7	6	1	0	100%	1
8A5W_E1U_D_401	55%	6%	0.184	0.953	2.97	2.02	6	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.